Argenx

About Argenx

Argenx is a biotechnology company focused on transforming immunology and delivering innovative medicines for patients with autoimmune diseases. The company is known for its first-in-class neonatal Fc receptor blocker, VYVGART, which has been approved for the treatment of generalized Myasthenia Gravis (gMG) and has the potential to address various severe autoimmune conditions.

Career Opportunities

Argenx offers a dynamic work environment that fosters professional growth and innovation. Employees are encouraged to collaborate and contribute to the company's mission of improving patient lives through cutting-edge science and technology.

• Innovative and collaborative work culture
• Opportunities for professional development and growth
• Commitment to making a difference for patients